immunogenicity and serum levels across imids
Published 9 years ago • 709 plays • Length 20:26Download video MP4
Download video MP3
Similar videos
-
2:53
what are immunomodulatory drugs (imids) and how do they work?
-
5:49
what are immunomodulatory drugs (imids) and how do they work?
-
3:26
how valuable is minimal residual disease testing for myeloma patients?
-
4:15
what are imids and how do they work?
-
13:20
immunogenicity overview of therapeutic biologics
-
5:59
what is hrmm (high-risk multiple myeloma)?
-
32:51
차세대 imid 신약 celmod, 승인 될까요 안될까요
-
5:59
antigens antibodies and interactions | immunity | don't memorise
-
5:59
evaluating immunogenicity risk of complex peptide products
-
6:22
what are antibody drug conjugates?
-
2:09
outcomes of pts with t(11;14) multiple myeloma: an imwg multicenter study
-
5:43
what is a celmod? how is it different from and imid?
-
1:08
the impact of extramedullary multiple myeloma on outcomes with ide-cel
-
5:53
immunoglobulin isotypes | antibody classes
-
4:34
what is ide-cel and how can it benefit myeloma patients?
-
1:50
real-world outcomes of teclistamab treatment in r/r multiple myeloma
-
0:21
sisaqol imi | glossary term: randomised clinical trial
-
5:30
revlimid mode of action video
-
1:01
how are elispot assays used for immunogenicity testing? | science in 60
-
57:28
biologics across immune mediated inflammatory disease from the rheumatology perspective
-
2:24
daratumumab plus vrd for multiple myeloma | nejm